To identify the occurrence of serotonin toxicity in Parkinson's Disease (PD) patients
receiving antidepressant therapy and rasagiline, compared to those receiving rasagiline
without antidepressant medications and compared to PD patients receiving antidepressants, but
not rasagiline.
Details
Lead Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc. Teva Pharmaceutical Industries